| |
| |
|
| Insider
Information: |
Gill Simba |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
51,819 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$710 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
51,819 |
|
|
| Total
Value |
$710 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Evelo Biosciences Inc |
EVLO |
President & CEO, Direc... |
2023-11-08 |
17,758 |
|
0 |
Premium* |
|
|
Foghorn Therapeutics Inc. |
FHTX |
|
2022-09-13 |
34,061 |
2022-09-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EVLO |
Evelo Biosciences Inc |
President & CEO |
• • – |
2023-11-08 |
4 |
AS |
$0.33 |
$57 |
D/D |
(172) |
17,758 |
0 |
% |
|
| EVLO |
Evelo Biosciences Inc |
President & CEO |
• • – |
2023-11-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,172 |
17,930 |
0 |
- |
|
| EVLO |
Evelo Biosciences Inc |
President & CEO |
• • – |
2023-09-28 |
4 |
AS |
$3.94 |
$7,864 |
D/D |
(1,996) |
16,758 |
0 |
% |
|
| EVLO |
Evelo Biosciences Inc |
President & CEO |
• • – |
2023-09-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
18,754 |
0 |
- |
|
| EVLO |
Evelo Biosciences Inc |
President & CEO |
• • – |
2023-08-08 |
4 |
AS |
$9.51 |
$3,252 |
D/D |
(342) |
3,754 |
0 |
% |
|
| EVLO |
Evelo Biosciences Inc |
President & CEO |
• • – |
2023-08-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,171 |
4,096 |
0 |
- |
|
| EVLO |
Evelo Biosciences Inc |
President & CEO |
• • – |
2023-05-08 |
4 |
AS |
$0.13 |
$444 |
D/D |
(3,537) |
58,512 |
0 |
% |
|
| EVLO |
Evelo Biosciences Inc |
President & CEO |
• • – |
2023-05-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,437 |
62,049 |
0 |
- |
|
| FHTX |
Foghorn Therapeutics Inc. |
|
– • – |
2022-09-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
47,939 |
34,061 |
0 |
- |
|
| FHTX |
Foghorn Therapeutics Inc. |
|
– • – |
2022-09-12 |
4 |
OE |
$0.73 |
$59,860 |
D/D |
82,000 |
82,000 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
